- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | VITURA HEALTH LIMITED: Change of Director's Interest Notice | - | ASX | ||
| Mo | VITURA HEALTH LIMITED: Cleansing Notice | - | ASX | ||
| Mo | VITURA HEALTH LIMITED: Application for quotation of securities - VIT | - | ASX | ||
| Mo | VITURA HEALTH LIMITED: Vitura completes acquisition of Canview platform | - | ASX | ||
| Mo | VITURA HEALTH LIMITED: H1 FY2025 financial results | - | ASX | ||
| Mo | VITURA HEALTH LIMITED: 2025 Half-Year Financial Report | - | ASX | ||
| VITURA HEALTH Aktie jetzt für 0€ handeln | |||||
| Mo | VITURA HEALTH LIMITED: Appendix 4D | - | ASX | ||
| Do | VITURA HEALTH LIMITED: Vitura completes acquisition of Candor Medical | 2 | ASX | ||
| 17.02. | VITURA HEALTH LIMITED: Update - Proposed issue of securities - VIT | - | ASX | ||
| 17.02. | VITURA HEALTH LIMITED: Becoming a substantial holder - updated | - | ASX | ||
| 14.02. | VITURA HEALTH LIMITED: Change in substantial holding | - | ASX | ||
| 13.02. | VITURA HEALTH LIMITED: Change of Substantial Holder - G Headley | 2 | ASX | ||
| 12.02. | XFRA 1CE0: WIEDERAUFNAHME/RESUMPTION | 70 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 12.02. | Health Check: Vitura Health swoops on medical dope telehealth platform | 1 | Stockhead | ||
| 11.02. | VITURA HEALTH LIMITED: Change of Substantial Holder - E Jansen | - | ASX | ||
| 11.02. | VITURA HEALTH LIMITED: Notice of Initial Substantial Holder - AFO | - | ASX | ||
| 11.02. | VITURA HEALTH LIMITED: Change of Substantial Holder - M Jansen | - | ASX | ||
| 11.02. | VITURA HEALTH LIMITED: Section 708A Cleansing Notice | - | ASX | ||
| 11.02. | VITURA HEALTH LIMITED: Application for quotation of securities - VIT | - | ASX | ||
| 11.02. | XFRA 1CE0: AUSSETZUNG/SUSPENSION | 438 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILVITURA HEALTH 1CE0... ► Artikel lesen |
Seite:
1 2 3 Weiter >>
55 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 5,250 | +3,24 % | Aurora Cannabis Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
| TILRAY BRANDS | 0,765 | -0,47 % | Tilray Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
| ORGANIGRAM | 1,140 | +1,97 % | Organigram Reports First Quarter Fiscal 2025 Results | TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced its results for the first quarter... ► Artikel lesen | |
| SNDL | 1,553 | +0,52 % | SNDL to Announce Fourth Quarter 2024 and Full Year 2024 Financial Results on March 18, 2025 | ||
| MYDECINE INNOVATIONS GROUP | 0,004 | -12,50 % | Mydecine Innovations Group Inc - Mydecine Announces Filing of Q3 Financial Statements | Mydecine Innovations Group Inc - Mydecine Announces Filing of Q3 Financial Statements
PR Newswire
LONDON, United Kingdom, November 21
MYDECINE ANNOUNCES FILING OF Q3 FINANCIAL... ► Artikel lesen | |
| BIONANO GENOMICS | 4,680 | -0,95 % | BNGO-Aktie erreicht 52-Wochen-Tief bei 4,75 US-Dollar | ||
| TONIX PHARMACEUTICALS | 8,360 | +4,11 % | Tonix Pharmaceuticals Holding Corp. - 8-K, Current Report | ||
| HIGH TIDE | 2,395 | +0,42 % | High Tide wurde von der TSX Venture Exchange zum zweiten Mal in Folge als Top 50-Unternehmen ausgezeichnet | Damit sichert sich das Unternehmen das dritte Mal innerhalb von vier Jahren einen Platz in diesem prestigeträchtigen Ranking
CALGARY, AB, 19. Februar 2025 / IRW-Press / High Tide... ► Artikel lesen | |
| JAGUAR HEALTH | 0,682 | -3,44 % | Jaguar Health, Inc.: Jaguar Receives Regulatory Clearance in Germany and Italy for Crofelemer for Rare Disease Study - Short Bowel Syndrome with Intestinal Failure | This study, initiated yesterday, is one of five clinical efforts - three proof-of-concept (POC) investigator-initiated trials (IIT) and two Phase 2 studies - of crofelemer for the rare disease indications... ► Artikel lesen | |
| ACHIEVE LIFE SCIENCES | 2,940 | +2,08 % | Achieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA Submission | Over 300 Participants Have Completed Cumulative Six Months of Cytisinicline Treatment in the ORCA-OL Trial, Completing the Long-Term Exposure Requirement for NDA Submission ORCA-OL Long-Term Exposure... ► Artikel lesen | |
| SEELOS THERAPEUTICS | 2,000 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.10.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 24.10.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.10.2024ISIN NameAU0000114977 BOOKTOPIA... ► Artikel lesen | |
| MEDIPHARM LABS | 0,046 | +1,33 % | MediPharm Labs Corp.: MediPharm Labs Reports Third Quarter Results | Strong Growth in International GMP Medical Markets
TORONTO, Nov. 14, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm"... ► Artikel lesen | |
| ARGENT BIOPHARMA | 0,077 | -12,07 % | Argent BioPharma Ltd. Updates on SINTEF Collaboration for Chronic Wound Management | Advanced wound care market projected to exceed $15 billion globally by 2030
PERTH, Australia, Feb. 12, 2025 /PRNewswire/ -- Argent BioPharma Ltd. (ASX: RGT)... ► Artikel lesen | |
| AYR WELLNESS | 0,360 | +2,13 % | Ayr Wellness Inc. - 6-K, Report of foreign issuer | ||
| BHANG | - | - | CSE Bulletin: Delist - Bhang Inc. (BHNG) | le 3 septembre/September 2024
The subordinate voting shares of Bhang Inc. will be delisted from the CSE at market close today, September 3, 2024.
Bhang Inc. is currently suspended. See Bulletin... ► Artikel lesen |
VITURA HEALTH LIMITED gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,045 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VITURA HEALTH LIMITED finden Sie auf Wallstreet Online.
